Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Class action filed
Director departure
Appointed director
CC transcript

INSPIRE PHARMACEUTICALS INC (ISPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2011 EFFECT Form EFFECT - Notice of Effectiveness
05/17/2011 EFFECT Form EFFECT - Notice of Effectiveness
05/16/2011 8-K Quarterly results
05/16/2011 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/16/2011 POS AM Form POS AM - Post-Effective amendments for registration statement
05/16/2011 POS AM Form POS AM - Post-Effective amendments for registration statement
05/16/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/16/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/16/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/16/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/16/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/16/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/16/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
05/16/2011 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
05/13/2011 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/13/2011 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/13/2011 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/11/2011 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/10/2011 8-K Other Events
05/10/2011 10-Q Quarterly Report for the period ended March 31, 2011
05/10/2011 8-K Form 8-K - Current report
05/04/2011 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/28/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
04/22/2011 8-K Form 8-K - Current report
04/22/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/22/2011 BW Inspire Postpones Annual Meeting of Stockholders Due to Recently Announced Tender Offer
04/15/2011 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership
04/15/2011 SC TO-T Form SC TO-T - Tender offer statement by Third Party
04/08/2011 BW The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH
04/07/2011 BW Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Inspire Pharmaceuticals, Inc. - ISPH
04/07/2011 BW The Law Firm of Weiss & Lurie Investigates the Acquisition of Inspire Pharmaceuticals, Inc.
04/06/2011 BW Law Office of Brodsky & Smith, LLC Announces Investigation of Inspire Pharmaceuticals, Inc.
04/06/2011 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
04/06/2011 BW The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy